Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
TyPed Study: Natalizumab for the Treatment of Pediatric-Onset Multiple Sclerosis in PortugalMult Scler Relat Disord 2021 Jun 01;51(xx)102865, F Palavra, S Figueiroa, AS Correia, F Tapadinhas, J Cerqueira, RP Guerreiro, J de Sá, MJ Sá, S Almeida, P Mota, L Sousa
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.